NO951444L - Gestagent aktive 19,11-broede 4-oestrener - Google Patents

Gestagent aktive 19,11-broede 4-oestrener

Info

Publication number
NO951444L
NO951444L NO951444A NO951444A NO951444L NO 951444 L NO951444 L NO 951444L NO 951444 A NO951444 A NO 951444A NO 951444 A NO951444 A NO 951444A NO 951444 L NO951444 L NO 951444L
Authority
NO
Norway
Prior art keywords
gestagent
oyster
trainer
breed
active
Prior art date
Application number
NO951444A
Other languages
English (en)
Other versions
NO951444D0 (no
NO305440B1 (no
Inventor
Eckhard Ottow
Wolfgang Schwede
Wolfgang Halfbrodt
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO951444D0 publication Critical patent/NO951444D0/no
Publication of NO951444L publication Critical patent/NO951444L/no
Publication of NO305440B1 publication Critical patent/NO305440B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Toys (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
NO951444A 1992-10-13 1995-04-12 Gestagent aktive 19,11-broede 4-°strener NO305440B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene
PCT/EP1993/002823 WO1994009025A1 (de) 1992-10-13 1993-10-13 Gestagen wirksame 19,11-überbrückte 4-estrene

Publications (3)

Publication Number Publication Date
NO951444D0 NO951444D0 (no) 1995-04-12
NO951444L true NO951444L (no) 1995-06-13
NO305440B1 NO305440B1 (no) 1999-05-31

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951444A NO305440B1 (no) 1992-10-13 1995-04-12 Gestagent aktive 19,11-broede 4-°strener

Country Status (25)

Country Link
US (2) US5523298A (no)
EP (1) EP0664811B1 (no)
JP (1) JP3302366B2 (no)
KR (1) KR100341066B1 (no)
CN (1) CN1052238C (no)
AT (1) ATE156837T1 (no)
AU (1) AU677019B2 (no)
BR (1) BR9307232A (no)
CA (1) CA2146962A1 (no)
CZ (1) CZ284187B6 (no)
DE (2) DE4235220A1 (no)
DK (1) DK0664811T3 (no)
ES (1) ES2108298T3 (no)
FI (1) FI951760A0 (no)
GR (1) GR3024940T3 (no)
HU (1) HU223315B1 (no)
IL (1) IL107232A (no)
NO (1) NO305440B1 (no)
NZ (1) NZ256865A (no)
PL (1) PL179764B1 (no)
RU (1) RU2157814C2 (no)
SK (1) SK280991B6 (no)
TW (1) TW341575B (no)
WO (1) WO1994009025A1 (no)
ZA (1) ZA937614B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
JP2004516841A (ja) * 2000-12-28 2004-06-10 シエーリング アクチエンゲゼルシャフト プロゲステロンレセプターアイソフォーム特異的リガンドおよび組織選択的プロゲステロンレセプターリガンドについてスクリーニングする方法
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
PL308349A1 (en) 1995-07-24
KR100341066B1 (ko) 2002-12-06
WO1994009025A1 (de) 1994-04-28
CA2146962A1 (en) 1994-04-28
FI951760A (fi) 1995-04-12
DE4235220A1 (de) 1994-06-16
NO951444D0 (no) 1995-04-12
CN1092428A (zh) 1994-09-21
IL107232A (en) 1998-06-15
JPH08502276A (ja) 1996-03-12
NO305440B1 (no) 1999-05-31
TW341575B (en) 1998-10-01
ES2108298T3 (es) 1997-12-16
EP0664811A1 (de) 1995-08-02
PL179764B1 (pl) 2000-10-31
RU2157814C2 (ru) 2000-10-20
AU5177493A (en) 1994-05-09
KR950703576A (ko) 1995-09-20
JP3302366B2 (ja) 2002-07-15
HUT71523A (en) 1995-12-28
NZ256865A (en) 1996-04-26
ZA937614B (en) 1994-05-23
SK280991B6 (sk) 2000-10-09
IL107232A0 (en) 1994-01-25
DK0664811T3 (da) 1998-03-30
DE59307133D1 (de) 1997-09-18
FI951760A0 (fi) 1995-04-12
CN1052238C (zh) 2000-05-10
RU95109891A (ru) 1997-02-10
HU223315B1 (hu) 2004-05-28
CZ91995A3 (en) 1995-09-13
SK49495A3 (en) 1995-08-09
ATE156837T1 (de) 1997-08-15
US5523298A (en) 1996-06-04
AU677019B2 (en) 1997-04-10
CZ284187B6 (cs) 1998-09-16
GR3024940T3 (en) 1998-01-30
US5703066A (en) 1997-12-30
HU9501057D0 (en) 1995-06-28
BR9307232A (pt) 1999-08-24
EP0664811B1 (de) 1997-08-13

Similar Documents

Publication Publication Date Title
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ATE175201T1 (de) Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
SE9504661D0 (sv) New compounds
GB9514473D0 (en) Chemical compounds
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
IL119207A0 (en) Treatment of tinnitus using neuroprotective agents
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
NO951444L (no) Gestagent aktive 19,11-broede 4-oestrener
DE69627344D1 (de) N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
TW252979B (no)
SE9504662D0 (sv) New compounds
IT1255461B (it) Eteri di imidazoli ad attivita' a ii antagonista
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
SE9603284D0 (sv) New compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees